본문으로 건너뛰기
← 뒤로

Favorable Clinical Response to Nivolumab and Radiotherapy in Advanced Metastatic Porocarcinoma: A Case Report.

증례보고 1/5 보강
International journal of dermatology 📖 저널 OA 23.1% 2021: 1/2 OA 2022: 0/4 OA 2023: 1/5 OA 2024: 4/6 OA 2025: 4/8 OA 2026: 7/28 OA 2021~2026 2026 Vol.65(4) p. 868-869 Bladder and Urothelial Cancer Treatm
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-04-30
OpenAlex 토픽 · Bladder and Urothelial Cancer Treatments Cancer and Skin Lesions Cancer Immunotherapy and Biomarkers

Ishida H, Makino T, Kitayama S, Kagoyama K, Mizawa M, Shimizu T

이 논문을 인용하기

↓ .bib ↓ .ris
APA Hiroaki Ishida, Teruhiko Makino, et al. (2026). Favorable Clinical Response to Nivolumab and Radiotherapy in Advanced Metastatic Porocarcinoma: A Case Report.. International journal of dermatology, 65(4), 868-869. https://doi.org/10.1111/ijd.70095
MLA Hiroaki Ishida, et al.. "Favorable Clinical Response to Nivolumab and Radiotherapy in Advanced Metastatic Porocarcinoma: A Case Report.." International journal of dermatology, vol. 65, no. 4, 2026, pp. 868-869.
PMID 41046323 ↗
DOI 10.1111/ijd.70095

같은 제1저자의 인용 많은 논문 (5)